Results 141 to 150 of about 1,488,165 (329)

1403 The EIF4 translational inhibitor pateamine a improves immunological and neurological functions in BXSB.yaa lupus mice [PDF]

open access: hybrid, 2021
Gonzalo Gómez-Hernández   +5 more
openalex   +1 more source

Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta   +18 more
wiley   +1 more source

Identification of Plasma Cell Subsets and Molecular Markers of Alzheimer’s Disease Based on Single-Cell Weighted Gene Co-Expression Network Analysis, Mendelian Randomization Analysis and Clinical Validation

open access: yesInternational Journal of General Medicine
Chao Xin,1,2 Hong-Wei Zhi,3 Da-Hua Wu,4 Peng-Li Ding,1 Zhong-Lin Wang,1,3 Ya-Han Wang4 1Shandong University of Traditional Chinese Medicine, Jinan, Shandong, People’s Republic of China; 2Affiliated Hospital of Shandong Academy of Traditional Chinese ...
Xin C   +5 more
doaj  

Loss-of-function in IRF2BPL is associated with neurological phenotypes [PDF]

open access: green, 2018
Paul C. Marcogliese   +42 more
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu   +9 more
wiley   +1 more source

Integrated Multi-Omics Profiling Identifies CD84-Associated Microglial Alterations in Focal Cortical Dysplasia Type II

open access: yesJournal of Inflammation Research
Yubao Fang,* Shengyu Yang,* Lei Lei,* Yinchao Li, Yaqian Zhang, Tiancai Huang, Liemin Zhou Department of Neurology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, People’s Republic of China*
Fang Y   +6 more
doaj  

Impact of Stress‐Induced Hyperglycemia on In‐Hospital Medical Complications in Patients With Acute Stroke: From a Large‐Scale Nationwide Longitudinal Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Aims This study aimed to explore the relationship between stress‐induced hyperglycemia (SIH) and in‐hospital medical complications in patients with acute stroke. Methods We enrolled 865,765 patients with acute stroke from the Chinese Stroke Center Alliance cohort.
Xintong Song   +6 more
wiley   +1 more source

Mental and neurological health profile of Ecuador [PDF]

open access: hybrid, 2008
Marcelo E. Cruz   +3 more
openalex   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic   +6 more
wiley   +1 more source

Atlas of Cerebrospinal Fluid Immune Cells Across Neurological Diseases [PDF]

open access: hybrid
Michael Heming   +15 more
openalex   +1 more source

Home - About - Disclaimer - Privacy